Atria Investments LLC Lantheus Holdings, Inc. Transaction History

Atria Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$77.7 - $123.62 $233,488 - $371,478	3,005 New	3,005 $329,000
Q2 2018 Jul 13, 2018	SELL	$13.65 - $18.7 $148,785 - $203,830	-10,900 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$14.85 - $24.3 $35,343 - $57,834	-2,380 Reduced 17.92%	10,900 $173,000
Q4 2017 Jan 16, 2018	BUY	$17.4 - $23.4 $231,071 - $310,752	13,280	13,280 $272,000

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Atria Investments LLC with notifications on news.